IL6 and ovarian cancer: Separately treatment with either FA-BSA-PTX or FA-BSA-CDF decreased cell viability of SKOV-3 ovarian cancer and HeLa cervical cancer cells Furthermore, the combination of FA-BSA-PTX and FA-BSA-CDF revealed synergism and enhanced cancer cell-killing effect (Gawde et al., 2018).